Angeline Bartholomeusz

Medicine · Health Sciences

34h-index5.0kcitations68works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(59), Hepatitis C virus research(57), Liver Disease Diagnosis and Treatment(21), HIV/AIDS drug development and treatment(16), Hepatitis Viruses Studies and Epidemiology(6)

Publications68 total

Replication of dengue virus RNA
Figshare·2021Open Access
Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody
Virology·2011· 62 cited
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)‐coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations
HIV Medicine·2009· 34 citedOpen Access
Modelling Hepatitis B Virus Antiviral Therapy and Drug Resistant Mutant Strains
Lecture notes in computer science·2009
A Systematic Review of T-cell Epitopes in Hepatitis B Virus: Identification, Genotypic Variation and Relevance to Antiviral Therapeutics
Antiviral Therapy·2008· 85 citedOpen Access
Genotype-Specific Genomic Markers Associated with Primary Hepatomas, Based on Complete Genomic Sequencing of Hepatitis B Virus
Journal of Virology·2008· 51 cited
Selection of Hepatitis B Virus (HBV) Vaccine Escape Mutants in HBV-Infected and HBV/HIV-Coinfected Patients Failing Antiretroviral Drugs With Anti-HBV Activity
JAIDS Journal of Acquired Immune Deficiency Syndromes·2007· 61 cited
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals
AIDS·2007· 40 cited
Antiviral drug-resistant HBV
Hepatology·2007· 447 citedOpen Access
The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro
Antimicrobial Agents and Chemotherapy·2007· 101 citedOpen Access
[512] HEPATITIS B VIRUS MUTANTS IN PATIENTS FAILING ANTIRETROVIRALS WITH ANTI-HBV ACTIVITY: IMPLICATIONS FOR DIAGNOSTICS AND VACCINE ESCAPE
Journal of Hepatology·2007Open Access
[486] UNDERSTANDING HBV RESISTANCE TO TELBIVUDINE: MOLECULAR MODELLING AND DATABASE MINING
Journal of Hepatology·2007· 3 cited
[505] MULTIDRUG RESISTANCE AND CROSS-RESISTANCE PATHWAYS IN HBV AS A CONSEQUENCE OF TREATMENT FAILURE
Journal of Hepatology·2007· 6 citedOpen Access
A systematic review of T-cell epitopes in hepatitis B virus: Identification, genotypic variation and relevance to antiviral therapeutics
UWA Profiles and Research Repository (University of Western Australia)·2007
SEQHEPB: A sequence analysis program and relational database system for chronic hepatitis B
Antiviral Research·2006· 72 cited
Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors
Journal of Gastroenterology and Hepatology·2006· 45 cited
Genome-wide characterisation of Hepatitis B mutations involved in clinical outcome
Heredity·2006· 19 citedOpen Access
Antiviral Drug Resistance: Clinical Consequences and Molecular Aspects
Seminars in Liver Disease·2006· 131 cited
400 Hepatitis B virus mutations involved in clinical outcome
Journal of Hepatology·2006Open Access
474 Hepatitis B virus genomic markers for hepatocellular carcinoma on full-genome sequencing of 332 patients
Journal of Hepatology·2006
page 1 of 4Next →

Frequent Co-authors

Stephen Locarnini(26), Anna Ayres(9), Sharon R. Lewin(7), Lilly Yuen(7), A. Ayres(6), Margaret Littlejohn(5), Danni Colledge(5), P. Angus(4), Scott Bowden(4), SA Locarnini(4), Peter Angus(3), William E. Delaney(3), Nadia Warner(3), Stephen Locarnini(3), Fabien Zoulim(3), Julie Sheldon(3), Michael J. Kuiper(3), Vincent Soriano(3), S. Locarnini(3), P.J. Wright(3)